Cutaneous adverse reaction of mogamulizumab, an anti-CC chemokine receptor 4 monoclonal antibody: Shared histopathological features with thymoma-associated multi-organ autoimmunity.

Kanno, Kyoko; Honma, Masaru; Ishida-Yamamoto, Akemi

Kanno, Kyoko; Honma, Masaru; Ishida-Yamamoto, Akemi.

Affiliation

Kanno K; Department of Dermatology, Asahikawa Medical University, Asahikawa, Japan.
Honma M; Department of Dermatology, Asahikawa Medical University, Asahikawa, Japan.
Ishida-Yamamoto A; Department of Dermatology, Asahikawa Medical University, Asahikawa, Japan.

J Dermatol ; 44(6): e117-e118, 2017 Jun.

Article in En | MEDLINE | ID: mdl-28026038

Subject(s)

Antibodies, Monoclonal, Humanized/adverse effects; Antineoplastic Agents/adverse effects; Autoimmunity/drug effects; Drug Eruptions/immunology; Aged; Humans; Leukemia-Lymphoma, Adult T-Cell; Receptors, CCR4/antagonists & inhibitors; Receptors, CCR4/immunology; Receptors, CCR4/metabolism; T-Lymphocytes/drug effects; T-Lymphocytes/immunology; T-Lymphocytes/metabolism; Thymoma/immunology; Thymus Neoplasms/diagnosis; Thymus Neoplasms/immunology

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Autoimmunity / Drug Eruptions / Antibodies, Monoclonal, Humanized / Antineoplastic Agents Type of study: Diagnostic_studies / Risk_factors_studies Limits: Aged / Humans Language: En Journal: J Dermatol Year: 2017 Document type: Article Affiliation country: Japan Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google